0001437749-21-028622.txt : 20211215 0001437749-21-028622.hdr.sgml : 20211215 20211215111957 ACCESSION NUMBER: 0001437749-21-028622 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211215 FILED AS OF DATE: 20211215 DATE AS OF CHANGE: 20211215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FINE N SCOTT CENTRAL INDEX KEY: 0001163556 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39780 FILM NUMBER: 211493492 MAIL ADDRESS: STREET 1: 600 3RD AVE CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclo Therapeutics, Inc. CENTRAL INDEX KEY: 0000922247 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 593029743 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6714 NW 16TH STREET, SUITE B CITY: GAINESVILLE STATE: FL ZIP: 32653 BUSINESS PHONE: 386-418-8060 MAIL ADDRESS: STREET 1: PO BOX 1180 CITY: ALACHUA STATE: FL ZIP: 32616-1180 FORMER COMPANY: FORMER CONFORMED NAME: CTD HOLDINGS INC DATE OF NAME CHANGE: 20000913 FORMER COMPANY: FORMER CONFORMED NAME: CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC DATE OF NAME CHANGE: 19941012 4 1 rdgdoc.xml FORM 4 X0306 4 2021-12-15 0000922247 Cyclo Therapeutics, Inc. CYTH 0001163556 FINE N SCOTT 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32163 1 1 Chief Executive Officer Common Stock 2021-12-15 4 P 0 5000 3.89 A 129666 D The price reported is a weighted average price. These shares of common stock were purchased in multiple transactions at prices ranging from $3.869 to $3.89, inclusive. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the foregoing ranges. /s/ N. Scott Fine 2021-12-15